Pharmacologic modulation of hand pain in osteoarthritis: A double-blind placebo-controlled functional magnetic resonance imaging study using naproxen

Arthritis and Rheumatology

Volumn 67, Issue 3, 2015, Pages 741-751

  Sanders, Duncan ^a,b   Krause, Kristina ^a,c   O'Muircheartaigh, Jonathan ^d   Thacker, Michael A ^e   Huggins, John P ^d   Vennart, William ^d   Massat, Nathalie J ^g   Choy, Ernest ^f   Williams, Steven C R ^a   Howard, Matthew A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NAPROXEN; PLACEBO; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; BOLD SIGNAL; BRAIN REGION; CARPOMETACARPAL JOINT; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAND PAIN; HUMAN; MALE; NOCICEPTION; OSTEOARTHRITIS; PAIN INTENSITY; PERSONAL EXPERIENCE; PRIMARY SOMATOSENSORY CORTEX; PRIORITY JOURNAL; SECONDARY SOMATOSENSORY CORTEX; SELF REPORT; TASK PERFORMANCE; THALAMUS; DRUG EFFECTS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PAIN MEASUREMENT; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARPOMETACARPAL JOINTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NAPROXEN; OSTEOARTHRITIS; PAIN; PAIN MEASUREMENT;

EID: 84923554197     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38987     Document Type: Article

References (48)

1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-96.
2. Fontana L, Neel S, Claise JM, Ughetto S, Catilina P,. Osteoarthritis of the thumb carpometacarpal joint in women and occupational risk factors: a case-control study. J Hand Surg Am 2007; 32: 459-65.
3. Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT,. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham Study. Am J Epidemiol 2002; 156: 1021-7.
4. Finan PH, Buenaver LF, Bounds SC, Hussain S, Park RJ, Haque UJ, et al. Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization. Arthritis Rheum 2013; 65: 363-72.
5. Gwilym SE, Keltner JR, Warnaby CE, Carr AJ, Chizh B, Chessell I, et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum 2009; 61: 1226-34.
6. Kupers R, Kehlet H,. Brain imaging of clinical pain states: a critical review and strategies for future studies. Lancet Neurol 2006; 5: 1033-44.
7. Seed SM, Dunican KC, Lynch AM,. Osteoarthritis: a review of treatment options. Geriatrics 2009; 64: 20-9.
8. Perez-Gutthann S, Garcia-Rodriguez LA, Duque-Oliart A, Varas-Lorenzo C,. Low-dose diclofenac, naproxen, and ibuprofen cohort study. Pharmacotherapy 1999; 19: 854-9.
9. Okie S,. A flood of opioids, a rising tide of deaths. N Engl J Med 2010; 363: 1981-5.
10. Dionne RA, Bartoshuk L, Mogil J, Witter J,. Individual responder analyses for pain: does one pain scale fit all? Trends Pharmacol Sci 2005; 26: 125-30.
11. Robinson ME, Staud R, Price DD,. Pain measurement and brain activity: will neuroimages replace pain ratings? J Pain 2013; 14: 323-7.
12. Wise RG, Preston C,. What is the value of human FMRI in CNS drug development? Drug Discov Today 2010; 15: 973-80.
13. Schweinhardt P, Bountra C, Tracey I,. Pharmacological FMRI in the development of new analgesic compounds. NMR Biomed 2006; 19: 702-11.
14. Baliki MN, Geha PY, Jabakhanji R, Harden N, Schnitzer TJ, Apkarian AV,. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Mol Pain 2008; 4: 47.
15. Parks EL, Geha PY, Baliki MN, Katz J, Schnitzer TJ, Apkarian AV,. Brain activity for chronic knee osteoarthritis: dissociating evoked pain from spontaneous pain. Eur J Pain 2011; 15: 843e1-14.
16. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990; 33: 1601-10.
17. Melzack R,. The short-form McGill Pain Questionnaire. Pain 1987; 30: 191-7.
18. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J,. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
19. Spielberger CD, Gorusch RL, Lushene R, Vagg PR, Jacobs GA,. State-Trait Anxiety Inventory for Adults. Redwood City (CA): Mind Garden; 1983.
20. MacDermid JC, Tottenham V,. Responsiveness of the disability of the arm, shoulder, and hand (DASH) and patient-rated wrist/hand evaluation (PRWHE) in evaluating change after hand therapy. J Hand Ther 2004; 17: 18-23.
21. Buxton RB, Uludag K, Dubowitz DJ, Liu TT,. Modeling the hemodynamic response to brain activation. Neuroimage 2004; 23 Suppl 1: S220-33.
22. Johnson AG, Nguyen TV, Day RO,. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121: 289-300.
23. Dai W, Garcia D, de Bazelaire C, Alsop DC,. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008; 60: 1488-97.
24. Howard MA, Sanders D, Krause K, O'Muircheartaigh J, Fotopoulou A, Zelaya F, et al. Alterations in resting-state regional cerebral blood flow demonstrate ongoing pain in osteoarthritis: an arterial spin-labeled magnetic resonance imaging study. Arthritis Rheum 2012; 64: 3936-46.
25. Woolrich M, Brady M, Smith S,. Model-based approaches to FMRI analysis [thesis]. London: Univ. of Oxford; 2001.
26. Woolrich M,. Robust group analysis using outlier inference. Neuroimage 2008; 41: 286-301.
27. Worsley KJ,. Statistical analysis of activation images. In:, Jezzard P, Matthews PM, Smith SM, editors. Functional MRI: an introduction to methods. 1st ed. Oxford: Oxford University Press; 2001. p. 251-70.
28. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK,. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005; 9: 463-84.
29. Coghill RC, Sang CN, Maisog JM, Iadarola MJ,. Pain intensity processing within the human brain: a bilateral, distributed mechanism. J Neurophysiol 1999; 82: 1934-43.
30. Bornhovd K, Quante M, Glauche V, Bromm B, Weiller C, Buchel C,. Painful stimuli evoke different stimulus-response functions in the amygdala, prefrontal, insula and somatosensory cortex: a single-trial fMRI study. Brain 2002; 125: 1326-36.
31. Faul F, Erdfelder E, Lang AG, Buchner A,. G Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91.
32. Ogawa S, Lee TM, Kay AR, Tank DW,. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990; 87: 9868-72.
33. Scrivani S, Wallin D, Moulton EA, Cole S, Wasan AD, Lockerman L, et al. A fMRI evaluation of lamotrigine for the treatment of trigeminal neuropathic pain: pilot study. Pain Med 2010; 11: 920-41.
34. Wise RG, Rogers R, Painter D, Bantick S, Ploghaus A, Williams P, et al. Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. Neuroimage 2002; 16: 999-1014.
35. Becerra L, Harter K, Gonzalez RG, Borsook D,. Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers. Anesth Analg 2006; 103: 208-16.
36. Apkarian AV, Baliki MN, Geha PY,. Towards a theory of chronic pain. Prog Neurobiol 2009; 87: 81-97.
37. May A,. Chronic pain may change the structure of the brain. Pain 2008; 137: 7-15.
38. Kriegeskorte N, Simmons WK, Bellgowan PS, Baker CI,. Circular analysis in systems neuroscience: the dangers of double dipping. Nat Neurosci 2009; 12: 535-40.
39. Melzack R,. Pain and the neuromatrix in the brain. J Dent Educ 2001; 65: 1378-82.
40. Kulkarni B, Bentley DE, Elliott R, Julyan PJ, Boger E, Watson A, et al. Arthritic pain is processed in brain areas concerned with emotions and fear. Arthritis Rheum 2007; 56: 1345-54.
41. Freynhagen R, Baron R, Gockel U, Tolle TR,. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911-20.
42. Kosek E, Ordeberg G,. Abnormalities of somatosensory perception in patients with painful osteoarthritis normalize following successful treatment. Eur J Pain 2000; 4: 229-38.
43. Graven-Nielsen T, Wodehouse T, Langford RM, Arendt-Nielsen L, Kidd BL,. Normalization of widespread hyperesthesia and facilitated spatial summation of deep-tissue pain in knee osteoarthritis patients after knee replacement. Arthritis Rheum 2012; 64: 2907-16.
44. Gwilym SE, Pollard TC, Carr AJ,. Understanding pain in osteoarthritis. J Bone Joint Surg Br 2008; 90: 280-7.
45. Moseley GL,. A pain neuromatrix approach to patients with chronic pain. Man Ther 2003; 8: 130-40.
46. Craig AD,. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002; 3: 655-66.
47. Woolf CJ,. Overcoming obstacles to developing new analgesics. Nat Med 2010; 16: 1241-7.
48. Borsook D, Becerra L, Hargreaves R,. Biomarkers for chronic pain and analgesia. Part 2. How, where, and what to look for using functional imaging. Discov Med 2011; 11: 209-19.